On July 28, 2026, six insiders at Scribe Therapeutics, Inc. (SCTX) executed a series of significant stock purchases, collectively acquiring approximately $108.35 million worth of shares. The transactions involved multiple large buy-ins at $15.00 per share and smaller acquisitions at $22.31 per share.
The purchasing insiders included Capital Advisors Llc Avoro, Behzad Aghazadeh, and Ventures Llc Avoro, all holding roles as Director and/or 10% Owner. Specifically, Capital Advisors Llc Avoro and Behzad Aghazadeh each purchased 2,333,333 shares at $15.00, totaling $35 million individually, alongside additional smaller purchases. Ventures Llc Avoro also made substantial purchases at both price points.
This cluster buying activity, where multiple insiders buy shares concurrently, is often interpreted as a strong bullish signal by market observers, suggesting a positive outlook on the company's future prospects.